Latest Breaking News On - Distress scale - Page 2 : comparemela.com

VistaGen Therapeutics (VTGN) Initiates PALISADE-3 Phase 3 Study of Fasedienol

VistaGen Therapeutics (VTGN) Initiates PALISADE-3 Phase 3 Study of Fasedienol
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn singhChief executiveSubjective unitsDistress scale

First Participant Enrolled in Phase 3 Trial of Fasedienol for Social Anxiety Disorder

Vistagen has enrolled the first participant in the PALISADE-3 phase 3 trial of fasedienol for the treatment of social anxiety disorder.

New york state psychiatric instituteNew yorkUnited statesColumbia universityShawn singhMichaelr liebowitzYork state psychiatric instituteDrug administrationResearch networkFast trackSubjective unitsDistress scaleLiebowitz social anxiety scaleAnxiety disorders clinicMedical research networkTales from

VistaGen Therapeutics, Inc (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript

VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.31.

Andrew tsaiMark mcpartlandPaul matisseShawn singhJosh princeCindy andersonVistagen therapeutics incChocolate companiesVistagen therapeuticsCall transcript februaryGen therapeuticsVistagen therapeutic fiscal yearQuarter financial resultsSenior vice presidentInvestor relationsChief executive officer

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update

Fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on trackPALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4 trial initiation anticipated in 2H 2024SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) $VTGN #mentalhealth Vistagen (Nasdaq: VTGN), a late clinical-stag.

United statesShawn singhMarka mcpartlandCompany phaseCompany quarterly report on formInternational number tollWomen health indicationsExchange commissionChief executive officerNasal sprayAcute treatmentSocial anxiety disorderSubjective unitsDistress scaleDrug applicationMajor depressive disorder

Experimental Evidence Shows That Housing Vouchers Provided Measurable Benefits, Including Parent Stress Reduction

Experimental Evidence Shows That Housing Vouchers Provided Measurable Benefits, Including Parent Stress Reduction
healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.

United statesAndrew fenelonChildren healthy developmentMacarthur foundation research network on housingRobert wood johnson foundationSupplemental nutrition assistance programExperimental housing allowance programDepartment of housingMacarthur foundationHuman developmentNational health interviewOpportunity for fair housing demonstration programTemporary assistanceNeedy familiesHealthy developmentUrban development